Immunotech Laboratories Inc. Stock Analysis IMMB
United States Health Care Nano Cap Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.
Read More Immunotech Laboratories Inc (IMMB) Chart
Key Statistics of Immunotech Laboratories Inc (IMMB)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
5000.00P/E Ratio (TTM)
-52 Week Range
Market Cap
57.50KAvg. Volume
5000.00Dividend Yield
-Financial Metrics & Statements of Immunotech Laboratories Inc (IMMB)
FAQ's for Immunotech Laboratories Inc (IMMB)
- According to Musaffa’s Shariah screening methodology, Immunotech Laboratories Inc (IMMB) is currently classified as NOT COVERED as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Alternate Halal Stocks for Immunotech Laboratories Inc (IMMB)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
